Latest Strategy News

Starpharma reports a significant 183% jump in FY25 revenue to $4.9 million, alongside a 31% reduction in losses and a solid cash position of $15.4 million. The biotech firm’s progress underscores growing momentum in its dendrimer technology pipeline.

Elanor Commercial Property Fund reported a solid FY25 with strong income and portfolio stability, while rejecting an unsolicited takeover bid from Lederer Group.

Havilah Resources has unveiled detailed plans for developing two significant copper deposits in South Australia’s Curnamona Province, highlighting robust resource bases and strategic infrastructure advantages.

Elanor Commercial Property Fund has met its FY25 earnings guidance with robust leasing activity and a strong occupancy rate, setting a stable foundation for FY26 despite market headwinds.

Elanor Commercial Property Fund reported a $5.4 million statutory loss for FY25 despite a slight increase in Funds from Operations, while navigating a strategic capital raise and an unsolicited takeover offer from the Lederer Group.

WAM Active Limited has announced a fully franked ordinary dividend of AUD 0.03 per share for the six months ending June 2025, accompanied by a Dividend Reinvestment Plan with no discount.

Kip McGrath Education Centres Ltd reported solid FY25 financial results with revenue and profit growth driven by franchise expansion and premium tutoring offerings. The company anticipates continued revenue growth and improved profitability in FY26 despite flat lesson volumes.

Intelligent Monitoring Group Limited (IMG) reported a 44% revenue surge to $174.9 million in FY25, driven by four key acquisitions and organic growth, while investing heavily in AI-powered video monitoring technology.

Earlypay Limited reported a 24% rise in underlying NPAT and a 30% increase in EPS for FY25, driven by strong growth in Equipment Finance that offset declines in Invoice and Trade Finance portfolios.

Emyria has begun treating the first Medibank-funded PTSD patients at its Perth clinic, marking a pioneering step in private insurance coverage for psychedelic-assisted therapy in Australia. This milestone fuels rapid clinic expansion and supports the company’s national rollout strategy.

Earlypay Limited reported a 24% rise in underlying net profit after tax for FY25, driven by robust growth in equipment finance and improved credit performance, while declaring a fully franked dividend and forecasting further earnings growth in FY26.

Earlypay Ltd reported a 31% rise in statutory net profit after tax for FY25, driven by growth in equipment finance despite declines in invoice and trade finance. The company declared a fully franked final dividend of 0.65 cents per share and outlined plans to expand its lending portfolios and streamline technology.